Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-048850·Novo Holdings A/S
Schedule 13G ownership disclosure
Zenas Biopharma Inc
Common Stock, par value $0.0001 · CUSIP: 98937L105
Event date: 2025-03-25
- Filing-level shares
- 2,214,967
- Percent of class
- 5.3%
- Novo Holdings A/S
Shares: 2,214,967 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-048850
- Form type
- SCHEDULE 13G
- Filer
- Novo Holdings A/S
- CIK
- CIK 1388325
- Filed
- Apr 01, 2025
- Reporting period
- Mar 25, 2025
- Description
- Schedule 13G beneficial ownership